Understanding the early clinical and pathological consequences of mitochondrial dysfunction in progressive MS.

被引:0
|
作者
Mahad, D. J. [1 ]
机构
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
74
引用
收藏
页码:32 / 32
页数:1
相关论文
共 23 条
  • [1] The evolving understanding of pathogenic mechanisms of progressive MS.
    Stadelmann, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 78 - 78
  • [2] Unraveling the cause of neuronal mitochondrial dysfunction in MS.
    Witte, M.
    Reynolds, R.
    Van Horssen, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 31 - 32
  • [3] Early cortical pathology and early relapses predict the risk of developing secondary progressive MS.
    Scalfari, A.
    Romualdi, C.
    Magliozzi, R.
    Mattoscio, M.
    Muraro, P.
    Nicholas, R.
    Calabrese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 57 - 58
  • [4] Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
    Bjartmar, C
    Wujek, JR
    Trapp, BD
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) : 165 - 171
  • [5] THE CLINICAL CONSEQUENCES OF DIETARY INTERVENTION IN CHILDREN WITH MITOCHONDRIAL DYSFUNCTION
    Zweers, H.
    Smeitink, J.
    De Vries, M.
    Morava, E.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 46 - 46
  • [6] Drug induced mitochondrial dysfunction: Mechanisms and adverse clinical consequences
    Vuda, Madhusudanarao
    Kamath, Ashwin
    MITOCHONDRION, 2016, 31 : 63 - 74
  • [7] Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's
    Toomey, Christina E.
    Heywood, Wendy E.
    Evans, James R.
    Lachica, Joanne
    Pressey, Sarah N.
    Foti, Sandrine C.
    Al Shahrani, Mesfer
    D'Sa, Karishma
    Hargreaves, Iain P.
    Heales, Simon
    Orford, Michael
    Troakes, Claire
    Attems, Johannes
    Gelpi, Ellen
    Palkovits, Miklos
    Lashley, Tammaryn
    Gentleman, Steve M.
    Revesz, Tamas
    Mills, Kevin
    Gandhi, Sonia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01):
  • [8] Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
    Christina E. Toomey
    Wendy E. Heywood
    James R. Evans
    Joanne Lachica
    Sarah N. Pressey
    Sandrine C. Foti
    Mesfer Al Shahrani
    Karishma D’Sa
    Iain P. Hargreaves
    Simon Heales
    Michael Orford
    Claire Troakes
    Johannes Attems
    Ellen Gelpi
    Miklos Palkovits
    Tammaryn Lashley
    Steve M. Gentleman
    Tamas Revesz
    Kevin Mills
    Sonia Gandhi
    Acta Neuropathologica Communications, 10
  • [9] Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia
    Rodriguez-Lopez, Claudia
    Garcia-Cardaba, Luis M.
    Blazquez, Alberto
    Serrano-Lorenzo, Pablo
    Gutierrez-Gutierrez, Gerardo
    San Millan-Tejado, Beatriz
    Muelas, Nuria
    Hernandez-Lain, Aurelio
    Vilchez, Juan J.
    Gutierrez-Rivas, Eduardo
    Arenas, Joaquin
    Martin, Miguel A.
    Dominguez-Gonzalez, Cristina
    JOURNAL OF MEDICAL GENETICS, 2020, 57 (09) : 643 - 646
  • [10] Clinical, pathological heterogeneity and mitochondrial dysfunction in patients with anti-mitochondrial antibodies related myositis
    Zhang, W.
    Wang, Y.
    Zhao, Y.
    Yuan, Y.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S98 - S98